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Abstract
Neurons are characterized by extremely long axons. This exceptional cell shape is likely to depend on multiple factors
including interactions between the cytoskeleton and membrane proteins. In many cell types, members of the protein 4.1
family play an important role in tethering the cortical actin-spectrin cytoskeleton to the plasma membrane. Protein 4.1B is
localized in myelinated axons, enriched in paranodal and juxtaparanodal regions, and also all along the internodes, but not
at nodes of Ranvier where are localized the voltage-dependent sodium channels responsible for action potential
propagation. To shed light on the role of protein 4.1B in the general organization of myelinated peripheral axons, we
studied 4.1B knockout mice. These mice displayed a mildly impaired gait and motility. Whereas nodes were unaffected, the
distribution of Caspr/paranodin, which anchors 4.1B to the membrane, was disorganized in paranodal regions and its levels
were decreased. In juxtaparanodes, the enrichment of Caspr2, which also interacts with 4.1B, and of the associated TAG-1
and Kv1.1, was absent in mutant mice, whereas their levels were unaltered. Ultrastructural abnormalities were observed
both at paranodes and juxtaparanodes. Axon calibers were slightly diminished in phrenic nerves and preterminal motor
axons were dysmorphic in skeletal muscle. bII spectrin enrichment was decreased along the axolemma. Electrophysiological
recordings at 3 post-natal weeks showed the occurrence of spontaneous and evoked repetitive activity indicating neuronal
hyperexcitability, without change in conduction velocity. Thus, our results show that in myelinated axons 4.1B contributes
to the stabilization of membrane proteins at paranodes, to the clustering of juxtaparanodal proteins, and to the regulation
of the internodal axon caliber.
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Introduction
A distinctive property of neurons is their extremely elongated
shape with an elaborate dendritic tree and axons that can be a
meter long, or more. The caliber of the axon is maintained
constant over long distances between bifurcations, with the
exception of regular changes at the level of nodes of Ranvier in
myelinated fibers. This regularity implies the existence of precise
molecular interactions between the membrane and the cortical
cytoskeleton which result in a regular curvature and a constant
diameter. In many cell types the actin-spectrin cytoskeleton
interacts with specific transmembrane proteins through linker
proteins, making up a highly ramified cortical network. One of the
major families of proteins involved in the interactions between the
cytoskeleton and the membrane are the band 4.1 proteins (for
review see [1]). Protein 4.1R, the first identified member of the
family, is a key protein in red blood cells, where it anchors the
actin-spectrin cytoskeleton to glycophorin C. This anchoring is
critical for the biconcave shape of red blood cells since mutations
in either protein 4.1R or glycophorin C result in hereditary
elliptocytosis and hemolytic anemia. The family encompasses five
members coded by different genes (4.1R, 4.1B, 4.1N, 4.1G and
4.1O), which can undergo alternative splicing [1,2]. 4.1B (also
termed type II brain 4.1, KIAA0987, EPB41L3) is highly enriched
in the brain [3,4]. A truncated form of 4.1B termed DAL-1 is a
tumor suppressor involved in the pathogenesis of non-small cell
lung and colorectal carcinomas, meningiomas, ependynomas, and
breast and prostate cancers [5–11].
The myelinated axons are organized in specialized domains
ensuring the rapid propagation of action potentials and are
characterized by the presence of specific proteins underlying
axoglial interactions (for review see [12,13]). Voltage-gated sodium
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from each other by myelin-covered internodes. On either side of
the nodes, axoglial interactions determine the formation of the
paranodes and juxtaparanodes. 4.1B is enriched in these two
domains, in both central and peripheral myelinated axons [14,15].
4.1B immunoreactivity has also been detected in the internodes
[14,16–18]. At paranodes and juxtaparanodes, 4.1B associates
with two proteins of the NCP (neurexinIV-caspr-paranodin)
family, Caspr/paranodin, and Caspr2, respectively [14,15,19].
These two proteins are highly homologous and share a
juxtamembrane cytoplasmic region which contains a 4.1-binding
motif (Glycophorin C, Neurexin IV, Paranodin, (GNP)) [15,20].
They both bind 4.1B FERM (four point one-ezrin-radixin-moesin)
domain in vitro and in vivo [15]. The localization of 4.1B in
peripheral myelinated axons occurs independently of the presence
of Caspr/paranodin at paranodes or Caspr2 at juxtaparanodes
[17,19,21–23], suggesting that it might be a primary component of
these regions. In the absence of 4.1B the juxtaparanodal
localization of Caspr2 is impaired [17,18]. To further address
the role of 4.1B in vivo we generated 4.1B knockout mice and
studied their phenotype. Our results support a role of 4.1B not
only at juxtaparanodes, but also at paranodes and in the
internodal region, suggesting that this protein contributes to the
maintenance of axon caliber and the myelinated fiber integrity.
Results
Protein 4.1B KO mice are viable and do not display major
developmental defect
Mutant mice were obtained using a three-lox recombination
strategy [24] to generate a protein 4.1B
KO3 allele deleted from the
exon 3 of the Dal-1 gene (Figure S1). Exon 3 of the Dal-1 gene
codes for the first amino acids of the FERM domain of protein
4.1B (Figure S2A). Its deletion was predicted to introduce a
premature stop codon and to lead to the production of a small
protein unable to interact with NCP-family proteins and the
cytoskeleton, if stable. Crossing heterozygous mice generated
litters in which the homozygous pups were obtained at a
Mendelian ratio (wild type: 26.6%; heterozygous: 46.8%;
homozygous: 26.6%; n=474) demonstrating that protein 4.1B is
not necessary for mouse development. When wild type brain or
sciatic nerve were analyzed by immunoblotting, several immuno-
reactive protein 4.1B bands were observed (Fig. 1A), in agreement
with the various reported splice isoforms [3,4,18,25]. These bands
were bona fide 4.1B since the immunoreactivity completely
disappeared in homozygous mutant mice, while intermediate
levels were observed in heterozygous mice (Fig. 1A). Interestingly,
the apparent molecular weight of these bands was different in
brain and sciatic nerves, reflecting a general difference in protein
4.1B isoforms expression between the central (CNS) and the
peripheral (PNS) nervous systems as demonstrated by immuno-
blotting of various peripheral nerves and CNS tissues from mouse
(data not shown) and rat (Figure S2B, C).
Protein 4.1B is localized all along the axolemma of
myelinated axons with the exception of nodes of Ranvier
Protein 4.1B was first reported to be enriched in the paranodal
and juxtaparanodal regions of PNS and CNS myelinated fibers
[14,15,21]. 4.1B immunoreactivity was also detected in the
internodes of myelinated axons [14,16–18]. However, this
immunoreactivity appeared non-homogenously distributed and
often less intense than at paranodes and juxtaparanodes. To
further characterize the localization of 4.1B, we performed
immunolabeling on teased sciatic fibers with tissue fixation and
post-fixation conditions different from those previously used (see
Materials and Methods). We observed that 4.1B immunoreactivity
extended beyond the juxtaparanodal region, lining continuously
the axolemma in the internode, with an intensity comparable to
that observed at paranodes and juxtaparanodes (Fig. 1B). In
agreement with this observation, in transverse sections of dorsal
spinal roots from wild type mice (WT), 4.1B immunoreactivity was
observed in all fibers as a ring surrounding neurofilaments
immunoreactivity (Fig. 1C). All the 4.1B immunoreactivity
disappeared in mutant mice (KO) (Fig. 1D). These results
demonstrated that protein 4.1B is localized at the vicinity of the
axolemma in myelinated fibers, not only in paranodal and
juxtaparanodal regions but also all along the entire length of the
axon, with the exception of the nodes themselves.
4.1B knockout mice display mild ataxia
4.1B mutant mice were normal in size and no significant
lethality was observed during the first 6 months of life, whereas in
older mutant mice the mortality increased significantly (Figure S3).
We examined the behavior of the adult mutant mice. During tail
suspension the animals had a posture of hind limb and forelimb
clasping (Fig. 1E) reported to occur in mouse models in which
there is neurological dysfunction [26,27]. They also had slight gait
abnormalities evidenced by the footprint test (Fig. 1F). The stride
length was decreased in young (4-month-old) as well as in older
(12-month-old) mice, while the stride width was normal (data not
shown). The alternation coefficient, reflecting the uniformity of
step alternation, was consequently significantly increased in
mutant mice as compared to WT mice (Fig. 1G). By contrast,
horizontal locomotor activity was not significantly altered (Fig. 1H).
The muscular strength was similar in both genotypes for front
limbs (Fig. 1I). No difference in reaction time was observed when
mice of two genotypes were placed on a hot plate (Fig. 1J),
indicating a lack of major alteration in nociception. Thus, changes
in gait without major motor deficit revealed an isolated ataxia in
4.1B knockout mice.
The localization and levels of paranodal proteins are
altered in sciatic nerves of 4.1B knockout mice
Since protein 4.1B is associated with Caspr/paranodin at
paranodes [15], we examined the distribution in teased fibers of
sciatic nerves of several proteins which are enriched in nodal and
paranodal regions. In 4.1B knockout mice, the distribution of
sodium channels (pan-Nav antibody) was normal (Fig. 2A, B), as
well as that of other nodal markers including ankyrin G (data not
shown). In contrast, paranodin labeling appeared less homoge-
neous and not as clearly limited as in WT paranodes (Fig. 2A, C).
In some nodes, paranodin immunoreactivity extended towards the
internodes, an aspect not observed in WT mice. Similar
observations were done using antibodies against contactin (data
not shown), which is associated in cis with paranodin in the axonal
paranodal regions [28]. The labeling for the 155-kDa isoform of
neurofascin, the partner of the paranodin/contactin complex
localized in the glial membrane [29–31], was similarly altered
(Fig. 2D, NF). Immunoblotting showed that the levels of
paranodin and contactin were significantly decreased in the sciatic
nerves of homozygous protein 4.1B mutant mice, but were
unaltered in heterozygotes (Fig. 2E, F), indicating that interme-
diate levels of protein 4.1B were sufficient to maintain normal
levels of contactin and paranodin. Since the intensity of the
immunoreactivity of paranodin and contactin at paranodes did not
appear significantly diminished, these results also suggest that a
larger proportion of the total pool of these proteins was targeted to
the paranodal axolemma in the absence of 4.1B. Similar
Role of Protein 4.1B in Myelinated Axons
PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e25043Figure 1. Identification and behavioral phenotype of 4.1B KO mice. A. Protein 4.1B expression in brains and sciatic nerves of WT (+/+), 4.1B
heterozygous (+/-) and homozygous (-/-) KO mice. B. Teased sciatic fibers from an adult WT mouse doubly stained for protein 4.1B (green) and
neurofilament subunit NF-M (red). Superposition of the two labels is shown (Merge). 4.1B is localized all along the axolemma of myelinated axons
with the exception of the node (arrowhead). C, D. Transversal sections of dorsal spinal roots from adult WT (C) and KO (D) mice, doubly stained for
protein 4.1B (green) and neurofilament subunit NF-M (red). Superposition of the two labels (Merge, C, D) and differential interference contrast (DIC, D)
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during development from post-natal day 5 to adulthood (data not
shown), indicating that the mislocalization of the paranodal
proteins occurred during development.
The juxtaparanodal proteins are mislocalized but their levels
are unchanged in sciatic nerves of 4.1B knockout mice
We then examined the organization of axonal proteins at
juxtaparanodes, where Caspr2 is associated with the glycosylpho-
sphatidyl- (GPI-) anchored protein TAG-1 in cis, in the
axolemma, and where this complex interacts in trans with another
molecule of TAG-1 in the Schwann cell membrane [22,32]. These
multimolecular complexes are important for the targeting of
Shaker-type K
+ channels (Kv1.1 and Kv1.2 subunits) [22,32]. In
4.1B mutant mice the distribution of Caspr2 and TAG-1
immunoreactivities were markedly decreased at juxtaparanodes,
with scattered clusters of weak labeling (Fig. 2B). The distribution
of Kv1.1 was also altered, but more variable (Fig. 2C, D). In most
cases, Kv1.1 was not or weakly enriched in the juxtaparanodal
regions (Fig 2C (d–i), D (d–i)). In other cases, Kv1.1 immunore-
activity at juxtaparanodes seemed less severely affected (Fig. 2C (j–
l), D (j–l)), but could also be found at paranodes (Fig. 2C (j–l), D (j–
l)). Immunoblotting showed that, in contrast to what was observed
for paranodal proteins, the levels of the three juxtaparanodal
proteins were not significantly altered in sciatic nerves from
mutant mice (Fig. 2E, F). Similar alterations of Caspr2 and TAG-1
distribution were observed at post-natal day 8 in KO pups (data
not shown).
Ultrastructural alterations of paranodal and
juxtaparanodal regions in the absence of protein 4.1B
At paranodes, the myelinating glial cell lateral loops spirally
wrap around the axon, and the glial membrane is tightly attached
to the axolemma by septate-like junctions. Five to ten nodes of
Ranvier were examined in longitudinal sections of sciatic nerves
from 4- and 13-month-old mice of each genotype (2 mice per
group) at the ultrastructural level. In WT mice, the paranodal
myelin loops were tightly and regularly positioned at paranodes,
with a symmetrical organization and size across the heminode
(Fig. 3A, B). Transverse bands were clearly visible (Fig. 3B,
arrowheads). In KO mice, paranodal loops were frequently
irregular but well organized transverse bands were still visible in
some regions of the paranodes (Fig. 3D, arrowheads), demon-
strating that 4.1B is not necessary for the formation of septate-like
junctions. However, abnormal interactions between axons and
glial cells were observed in KO mice as compared to WT mice
(Fig. 3E and F, arrows). At juxtaparanodes, cytoplasmic Schwann
cell protruded in the axon (Fig. 3F, arrows; 4-month-old mice, 19
juxtaparanodal regions affected out 32 observed; 13-month-old
mice, 16 juxtaparanodal regions affected out 30 observed).
The distribution of axonal bII spectrin is altered in the
absence of protein 4.1B
A major function of proteins 4.1 is to anchor the cortical
spectrin-based cytoskeleton to the cell membrane and, thus,
contribute to the control of cell shape [1]. bII spectrin
immunoreactivity was previously reported at paranodes and
juxtaparanodes in optic and sciatic nerves, as well as all along
the optic axons [16]. An association between protein 4.1B and bII
spectrin was also detected in mouse brain lysates [16]. Thus, we
carefully examined the distribution of bII spectrin in WT and
mutant mice (Fig. 4). When we fixed WT dissociated sciatic fibers
using the similar conditions used for 4.1B detection, we noticed
that, as for protein 4.1B, bII spectrin immunoreactivity lined the
axolemma along the whole length of the axon (Fig. 4A (a–c)), with
the exception of the node of Ranvier (Fig. 4A (e–g, arrowheads)).
Immunoreactivity was also observed along the abaxonal mem-
brane of Schwann cells (Fig. 4A (b, f)). In mutant mice some bII
spectrin immunoreactivity was still detectable along the axolemma
(Fig. 4A (d, h)), but was also detectable in the node (Fig. 4A (h,
arrowhead)). To better visualize bII spectrin localization we
examined transversal sections of dorsal spinal roots (Fig. 4B (a–c)).
In these preparations, concentric circles of axonal and glial bII
spectrin immunoreactivity were observed in WT mice, with the
inner (axonal) one being also labeled with 4.1B antibodies. In
mutant mice, the inner ring of immunoreactivity was much less
regular and intense as compared to the glial ring of immunore-
activity (Fig. 4B (d), 4C). However, the levels of bII spectrin were
not significantly decreased in 4.1B mutant mice compared to WT
mice (Fig. 4D, E). These results showed that bII spectrin is also
localized all along the axon and that its distribution is altered in
the absence of protein 4.1B, suggesting that 4.1B mutant mice
could present axonal internodal defects.
4.1B KO mice present internodal axon and myelin defects
We started to study the internodal region in transverse sections
of phrenic nerves. In semi-thin sections at low magnification
(Fig. 5A), the number of fibers was not decreased in 4-, 8- and 13-
month-old knockout mice, as compared to WT littermates (data
not shown). Analysis of ultrathin sections at low magnification
showed no change in the fiber diameter at 4 and 13 months
(Fig. 5B), whereas the axonal diameter was decreased in knockout
mice at both ages (211.7% and 219.7%, respectively, Fig. 5B).
Consequently, the myelin thickness was relatively increased in the
mutant mice, as indicated by a slight decrease in the G-ratio
(Fig. 5B).
To investigate whether KO mice present additional internodal
alterations, we examined dissociated fibers from the sciatic nerve,
which display a wide range of caliber. We analyzed the internodal
length determined as the distance between two nodes stained for
Nav and found a slight decrease in the mean value of this
parameter (WT, 570 6 10 mm, KO, 542 6 8.9 mm; unpaired t-
test, *p,0.05; WT, n=179, KO, n=137). A more detailed
analysis revealed that the distribution histogram of internodal
lengths was less spread in KO than in WT mice, with more than
40% of the fibers with an intermodal length of 500–600 mm
(Fig. 5C). When we plotted the internodal length as a function of
the fiber diameter, we observed a significant correlation (Fig. 5D),
as expected [33]. However, the slopes were slightly but
significantly different between the two genotypes, with a lesser
are shown. 4.1B staining, encircling the NF-M positive axoplasm, is visualized only on the surface of the fibers in the WT mouse (C) and is absent in the
4.1B KO mouse (D). E. Limb clasping of a KO mouse compared to a WT littermate. F. Representative footprint patterns of 4-month-old WT and KO
mice. Vertical and horizontal bars on the WT pattern represent stride length (SL) and stride width (SW) measures, respectively. G. Alternation
coefficient of 4-month-old WT (n=3) and KO (n=4) mice, and 12-month-old WT (n=4) and KO (n=5) mice. H. Spontaneous locomotor activities of 4-
to 6-month-old WT (n=10) and KO (n=18) mice measured during 3 consecutive days. I. Forelimb grip strength analysis of 4- to 6-month-old WT
(n=15) and KO (n=12) mice. J. Heat sensitivity of 4- to 5-month-old WT (n=7) and KO (n=7) mice. Statistical analysis, 2-way ANOVA followed by
Bonferonni post-test (H, *p,0.05), 2-way RM ANOVA (I, p.0.05), unpaired t-test (J, P=0.87). Scale bars: 10 mm.
doi:10.1371/journal.pone.0025043.g001
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KO mice.
We also quantified the number of Schmidt-Lanterman incisures
(SLIs), which are helicoidal cytoplasmic channels through the
compact myelin of Schwann cells. SLIs are characterized by the
presence of Schwann cell autotypic contacts where are localized
cadherins, catenins, claudins, connexins and neurofascin 155-kDa
isoform (NF155) [34,35]. We visualized the SLIs in teased sciatic
fibers by NF155 immunostaining. We observed that the number of
SLIs/mm was significantly increased in 4.1B mutant mice (Fig. 5E,
F). In agreement with this finding, immunoblot analysis revealed
increased levels of b-catenin and NF155 (Fig. 5G).
Internodal changes were not accompanied by dramatic changes
in the major protein components of myelin or axonal cytoskeleton.
No alteration in the levels of two major proteins of the myelin
sheath, P0 and myelin basic protein (MBP), the three subunits of
neurofilaments, NF-L, NF-M, and NF-H, as well as phosphory-
lated NF-H (NF-H-Ph) and actin, was observed in sciatic nerves of
WT, heterozygous, and homozygous mutant mice (Figure S4A-D).
Motor axons are altered in the absence of protein 4.1B
To further investigate how the absence of protein 4.1B could
affect the morphology of axons, we studied the motor axons in
skeletal muscle where they reach their target. Labeling of
neuromuscular junctions (NMJ) was performed on hind limb
muscles (tibialis anterior or extensor digitorum longus)f r o mW Ta n d
4.1B mutant mice. Whole mount preparations of muscle fibers
were stained with rhodamine-conjugated a-bungarotoxin and a
monoclonal antibody directed against the neurofilament subunit
NF-M to label the acetylcholine receptors (AChR) and axons,
respectively (Fig. 6). The WT preterminal axons had a relatively
regular caliber (Fig. 6A, B). In contrast, an irregular swollen
aspect of NF-M-positive preterminal axons was observed in
mutant mice, alternating with narrow segments (Fig. 6C, D,
arrowheads). These axonal swellings were only observed in
preterminal myelinated axons and not in terminal axons in the
synaptic gutter stained with a-bungarotoxin. These findings
further indicated an abnormal axonal structure in the absence of
protein 4.1B.
Figure 3. Ultrastructure of nodal regions in 4.1B KO mice. Electron micrographs of longitudinal sections of sciatic nerves, at the level of nodes
of Ranvier, from WT (A, B (higher magnification of box in A), E) and KO mice (C, D (higher magnification of box in C), F). In the WT mouse, paranodal
loops are symmetrical across the axon (A), and transverse bands are visible at the paranodal junctions (B, arrowheads). In the paranodal regions of the
KO mouse irregular paranodal loops are frequently observed (C, D), transverse bands between the axolemma and some glial loops are not apparent
in some places (D, arrows), but clearly visible in others (D, arrowheads). At juxtaparanodes, cytoplasmic Schwann cell protrusions in the axon are
observed in mutant mice (F, arrows) but not in WT mice (E, arrows). Scale bar: A, C, 0.7 mm; B, D, 0.3 mm; E, F, 0.9 mm.
doi:10.1371/journal.pone.0025043.g003
Figure 2. Distribution and expression levels of paranodal and juxtaparanodal proteins in sciatic nerves of 4.1B KO mice. A–D.
Immunolocalization of Nav (red, A, B), Caspr/paranodin (Pnd, green, A, C), Caspr2 (green, B), TAG-1 (green, B), Kv1.1 subunits (Kv1.1, red, C, D), and
neurofascin (NF, green, D) in teased sciatic fibers from adult WT and KO mice. Single labels and superpositions (Merge) are shown. Arrowheads,
nodes. In KO mice, paranodin and neurofascin labeling appears less homogeneous and not as clearly limited as in WT paranodes (A, C, D). The
distribution of Caspr2 and TAG-1 immunoreactivities are markedly decreased at juxtaparanodes (B). In most cases, Kv1.1 are not or weakly enriched in
the juxtaparanodal regions (C (d–i), D (d–i)). In other cases, Kv1.1 immunoreactivity at juxtaparanodes seems less severely affected (C (j–l), D (j–l)), but
can also be found at paranodes (C (j–l)). E, F. Proteins expression in sciatic nerves from adult WT (+/+), heterozygous (+/-) and homozygous (-/-)
mutant mice evaluated by immunoblotting (E), and quantified and normalized to b-tubulin signal (F, three mice for each genotype). The levels of
paranodin and contactin are significantly decreased in homozygous mutant mice compared to WT mice, whereas the levels of the three
juxtaparanodal proteins are not significantly altered. Statistical analysis, 1-way ANOVA followed by Bonferroni’s multiple comparison test, **p,0.01,
***p,0.001. Scale bars: 10 mm.
doi:10.1371/journal.pone.0025043.g002
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but display transient temperature sensitive
hyperexcitability
We finally investigated whether the morphological abnormal-
ities observed in mutant mice may influence peripheral nerve
functions. To this end, we first examined the electrophysiological
properties of the sciatic nerves of 5-month-old mutant mice
compared to WT littermates. Recording from sciatic nerves did
not reveal any alteration in the shape of compound action
potentials (CAPs) at 35uC (Figure S5A) or 22uC (data not shown).
Although the conduction velocity (CV) of CAPs was slightly
decreased in mutant mice, the difference with their WT littermates
was not significant (Table 1). The CV of C fibers was also not
significantly affected and no conduction block was observed (data
not shown). The refractory period was virtually identical in both
genotypes at 35uC (Figure S5B) or 22uC (data not shown). The
recruitment of the CAPs was similar in WT and mutant mice
(Figure S5C). These basic parameters were also unaltered in the
presence of increased extracellular K
+ (9 mM) or of K
+ channel
blockers tetraethylammonium (TEA, 10 mM) and 4-aminopyr-
idine (4-AP, 500 mM), alone or in combination, or following
repeated stimulation (data not shown).
We next examined whether 4.1B mutant animals exhibited
neuromuscular alterations, and we recorded the diaphragm
compound muscle action potential (CMAPs) in response to the
stimulation of the phrenic nerve in 3-week-old mice (Fig. 7A).
CMAPs had a typical triphasic shape in both mutant and WT
littermates (Fig. 7B). Following a single stimulation, repetitive
activity was recorded in 4.1B KO mice at 20uC, but neither in WT
mice (Fig. 7B) nor at 37uC (not shown). In addition, spontaneous
muscle activity was observed in mutant mice at 20uC, but neither
Figure 4. Abnormal distribution of bII spectrin in axons of 4.1B KO mice. A. Teased sciatic fibers from adult WT (a–c and e–g) and KO (d, h)
mice double stained for protein 4.1B (green) and bII spectrin (red). Superpositions of the two labels (Merge, WT, c, g, KO, d, h) are shown. As for
protein 4.1B, in WT mice bII spectrin immunoreactivity lined the axolemma along the whole length of the axon with the exception of the node (e–g,
arrowheads). In mutant mice some bII spectrin immunoreactivity is still detectable along the axolemma (d, h), and at the node (h, arrowhead). B.
Transversal sections of dorsal spinal roots from adult WT (a–c) and KO (d) mice doubly stained for protein 4.1B (green) and bII spectrin (red).
Superpositions of the two labels (Merge, WT, c, KO, d) are shown. Concentric circles of axonal and glial bII spectrin immunoreactivity are observed in
WT mice, with the inner (axonal) one being also labeled with 4.1B antibodies (a–c). In mutant mice, the inner ring of immunoreactivity is much less
regular and intense relatively to the glial ring of immunoreavtivity (d). C. Representative fluorescence intensity profiles of bII spectrin labeling of
dorsal spinal root myelinated fibers from WT and KO mice. Arrowheads, axonal labeling; asterisks, glial cells abaxonal membrane labeling. D, E. bII
spectrin expression in sciatic nerves from adult WT mice (+/+), heterozygous (+/-) and homozygous (-/-) mutant mice evaluated by immunoblotting
(D), and quantified and normalized to b-tubulin signal (E, three mice for each genotype). Statistical analysis, 1-way ANOVA followed by Bonferroni’s
Multiple Comparison Test. No significant change was observed between the different genotypes. Scale bars: 10 mm.
doi:10.1371/journal.pone.0025043.g004
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4.1B-deficient animals presented cooling-induced hyperactivity
similar to that observed in mice deficient for the voltage-sensitive
potassium channels Kv1.1 (Kcna1-null mice) [36,37]. Repetitive
muscle contractions were not observed after direct stimulation of
the diaphragm muscle, indicating they did not originate in the
muscle (Fig. 7D). Similarly to Kcna1-null mice, we found that the
repetitive and spontaneous activities were markedly increased in
the presence of 5 mM TEA at 20uC (Fig. 7B, E). In particular,
TEA elicited repetitive activities in phrenic nerve axons (Fig. 7F),
suggesting that hyperactivity had an axonal origin and back-
propagated in the axons. This hypothesis was further confirmed by
the blockade of muscular repetitive activity induced by phrenic
stimulation in the presence of D-tubocurarine (Fig. 7E), which
Figure 5. Internodal abnormalities in phrenic and sciatic nerves from 4.1B mutant mice. A. Electron micrographs from transverse sections
of phrenic nerves of 4-month-old WT and KO mice. B. Fiber diameter, axonal diameter, and G-ratio in phrenic nerves of 4- or 13-month-old WT and
KO mice. The size of the axons was slightly reduced and the thickness of the myelin sheath increased in KO mice. Statistical analysis, Mann-Whitney
test, ** p,0.01, ***p,0.001 (B). C. Internodal length class histogram distribution of myelinated segments from sciatic nerves of 6-month-old WT and
KO mice. Internodal lengths are less spread in KO than in WT mice, with more than 40% of the fibers with a fiber diameter of 500–600 mm. Statistical
analysis, Chi 2=27.77, p =0.0001. D. Correlation of internodal length with nerve fiber diameter. The slopes are significantly different between the
two genotypes: WT, 33.5 6 2.5 (r
2=0.49); KO, 21.0 6 3.2 (r
2=0.24). Linear regression, p,0.01. E. Visualization of Schmidt-Lanterman incisures (SLIs,
NF155 labeling, in green, asterisks) and nodes (Nav labeling, in red, arrowheads) in teased sciatic fibers from adult WT and KO mice. n, nuclei of the
Schwann cells stained with DAPI (blue). F. Quantification of the average number of SLIs per mm in sciatic nerves from adult WT and KO mice.
Statistical analysis, two-tailed t-test, *** p,0.0001. G. NF155 and b-catenin expression in sciatic nerves from adult WT and KO mice evaluated by
immunoblotting (data not shown), and quantified and normalized to b-tubulin signal (three mice for each genotype). Levels of b-catenin and NF155
are significantly increased in KO mice compared to WT mice. Unpaired t-test, * p,0.05, ** p,0.005. Scale bars: A, 10 mm; E, 50 mm.
doi:10.1371/journal.pone.0025043.g005
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transmission, whereas this treatment had no effect on the repetitive
activity recorded in the nerve (Fig. 7F). When we recorded in mice
at various ages from 2 to 25 weeks, we observed the evoked and
spontaneous hyperactivity only around 3 weeks (Figure S6),
showing that this was a transient phenomenon during develop-
ment. These results demonstrate that in the absence of protein
4.1B, a transient nervous hyperexcitability arises that is masked
almost completely by compensatory effects of K
+ channels, as
revealed by TEA blockade.
Discussion
The results reported here demonstrate the importance of
protein 4.1B in the organization of myelinated axons. It had been
previously shown that 4.1B interacts with two proteins enriched in
paranodal and juxtaparanodal regions, Caspr/paranodin and
Caspr2, respectively [15] through their GNP motif [20]. The
present study supports a functional role of these interactions and
expands the role of 4.1B to the internodal regions.
The paranodes serve as a membrane barrier that excludes
juxtaparanodal components from the node [19,23,30,38,39]. In
4.1B mutant sciatic nerves we observed that the absence of 4.1B
did not prevent the targeting of paranodin or its axonal partner
contactin at paranodes. However, the levels of expression of these
proteins were decreased and their distribution was altered.
Paranodes appeared non homogeneous and with less clearly
defined limits than in WT mice. This altered distribution of the
paranodal proteins affected the localization of the juxtaparanodal
K
+ channels which were at times mislocalized at the paranodes.
Thus, our results support a role of protein 4.1B in the membrane
trafficking and stabilization of the paranodal complexes in the
axonal membrane, contributing to the paranodal membrane
barrier establishment. It is likely that protein 4.1B could play this
role through its association with the spectrins (aII and bII
spectrins) localized in the paranodes [16]. Interestingly, at the
ultrastructural level, paranodal transverse bands between the
axolemma and glial loops were still detectable in some places in
4.1B mutant mice, demonstrating that 4.1B is not necessary for
their formation.
Our observations on the role of 4.1B on paranodes organization
in the PNS are in agreement with previous results showing that
stable expression and localization of paranodin at the paranodes in
transgenic mice requires its intracellular 4.1-binding motif [21].
Furthermore, they are in accordance with the results observed
recently by others in mutant mice obtained using a two-lox
recombination strategy to generate a mutant allele deleted from
the exon 6 of the 4.1B locus (b-Act-Cre;4.1B
Flox mice) [18]. The
distribution of paranodin and NF155 was also disorganized in the
paranodal regions of these mice. Paranodes often displayed severe
morphological defects, but array of transverse bands could be
found. However, our observations differ from those reported in an
alternative model of mice deficient for the expression of 4.1B
generated using a conventional recombination method to delete
the exon 3 of the DAL-1 gene [40]. In these mice (referred to below
as ‘‘4.1B-null’’ mice) paranodin, contactin, and NF155 were found
to be correctly localized in the paranodal regions and Kv1
Figure 6. Alteration of preterminal axons of motor endplates in
4.1B KO mice. In toto immunostaining of neuromuscular junctions on
preparations of teased fibers from WT (A, B) and KO (C, D) mice with
rhodamine-conjugated a-bungarotoxin (red) and antibodies directed
against neurofilament subunit NF-M (green). NF-M labeling revealed
irregular caliber with dilated segments in myelinated preterminal axons
of the KO mouse (C, D, arrowheads). Scale bars: A, C, 75 mm; B, D,
15 mm.
doi:10.1371/journal.pone.0025043.g006
Table 1. Electrophysiological characteristics of sciatic nerves of WT and KO mice at 35uC and 22uC.
T6C Genotype CAP
1 amplitude (mV) CVVmax
2 (m.s
21)C V V1/2 (m.s
21) DurationV1/2 (ms) CAP area (10
26V.s)
35uC WT 11.663.3 39.466.8 66.669.0 0.3760.06 25686626
35uC KO 10.064.8 34.466.7 57.3611.3 0.3760.04 22646978
22uC WT 10.863.3 19.663.0 39.864.9 0.9160.07 602462165
22uC KO 10.663.2 18.161.7 36.064.6 0.8960.05 531661726
The data were recorded from 9 and 10 sciatic nerves from 5-month old WT and KO mice, respectively. Electrophysiological characteristics of sciatic nerves of WT and KO
mice are not significantly different (two-tailed t-test for two samples of equal variance).
1CAP, compound action potential.
2CV, conduction velocity.
doi:10.1371/journal.pone.0025043.t001
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PLoS ONE | www.plosone.org 9 September 2011 | Volume 6 | Issue 9 | e25043Figure 7. Neuromuscular electrophysiological properties of WT and 4.1B KO mice. A. Nerve (CAP) and muscle (CMAPs) compound action
potentials recording protocol. The CMAPs were recorded with a surface electrode pressed on the diaphragm (1) after stimulation of the phrenic nerve
(A) or the diaphragm (B) using bipolar electrodes. The phrenic nerve CAPs (2) were simultaneously recorded from the cut end with a suction
electrode. B. Typical CMAPs recorded from diaphragms of P21 WT and KO mice after phrenic nerve stimulation at 20uC in the absence and in the
presence of the potassium channel blocker TEA. C. Muscle spontaneous activity recorded from P21 WT and KO mice at 21uC and 37uC in the presence
of the potassium channel blocker TEA. D. Repetitive activity is recorded in the diaphragm of KO mice following stimulation of the phrenic nerve
(upper trace, arrow) but not of the muscle fibers (lower trace). E. In the diaphragm, repetitive activity is elicited by the blockade of potassium
channels with TEA (5 mM, arrows), and prevented in the presence of D-tubocurarine (20 mM), indicating that it originates in the axons. F. TEA also
elicits repetitive activity (arrows) in the phrenic nerve axons insensitive to D-tubocurarine.
doi:10.1371/journal.pone.0025043.g007
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A possible explanation for the differences between mutant mouse
models could be related to the differences in their 4.1B locus
mutations and/or their genetic backgrounds. Supporting this
hypothesis, ‘‘4.1B-null’’ mice did not show neurological abnor-
malities and no difference in the longevity compared to WT
littermates [40], in contrast with our 4.1B KO mice. It is also
possible that other types of protein 4.1 compensate for the absence
of 4.1B. Although we did not detect an increase in 4.1N in sciatic
nerve extracts (Goutebroze, unpublished observations), the normal
levels of this isoform, or possibly others may be sufficient to take
over some of the functions of 4.1B.
In the absence of protein 4.1B, we also observed that the
distribution of the main proteins of juxtaparanodes was profoundly
altered. The enrichment of both Caspr2 and TAG-1 was almost
completely lost, showing that protein 4.1B is required for the
correct localization of these molecules, in agreement with the
results observed by other groups using different mouse models
[17,18,21]. In addition, we observed that Caspr2 and TAG-1 were
not detected at juxtaparanodes during development, suggesting
that protein 4.1B controls the accumulation of Caspr2 at the
juxtaparanodes rather than its stabilization in the axonal
membrane. Consistent with this hypothesis, the levels of Caspr2
and TAG-1 were not decreased in adult mutant mice, showing
that there was no destabilization, at least no degradation of the
Caspr2/TAG-1 complexes, and that they were probably redis-
tributed along the internodes. Importantly, in TAG-1 mutant mice
the distribution of 4.1B was not altered, showing that its
enrichment is not dependent on the Caspr2/TAG-1 membrane
proteins complexes [22]. Thus, our results strengthen the
hypothesis that 4.1B plays the primary role in the localization of
these complexes to juxtaparanodes. Moreover, our observations
showing Schwann cells protrusions in the axon in nearly half of
sciatic nerve juxtaparanodal regions observed in the mutant mice,
indicate that 4.1B might be required, directly or indirectly, in the
structural organization of the juxtaparanodes.
Important components of juxtaparanodal membranes are the
Shaker-type K
+ channels Kv1.1 and Kv1.2 [41]. Kv1.1/2 channels
localization depends in part on both TAG-1 and Caspr2 [22,32].
Caspr2 was originally thought to control Kv1.1/2 clustering
through their PDZ binding motif and through the PDZ proteins,
PSD93 and PSD95, expressed at juxtaparanodes. However,
Kv1.1/2 clustering is not affected in mice deficient for PSD-93
and/or PSD-95 [42,43] and in mutant mice expressing Caspr2
lacking its carboxy-terminal PDZ-binding motif [42]. Instead,
Kv1.1/2 clustering appears to require the 4.1-binding region of
Caspr2 [17]. We found that the enrichment of Kv1.1/2 at
juxtaparanodes was highly altered in 4.1B knockout mice, with the
exception of some remaining clusters. Thus, our results also
support the important role of protein 4.1B in Kv1.1/2 channels
accumulation at juxtaparanodes.
Interestingly, the electrophysiological phenotype of 4.1B mutant
mice is likely to result in part from the mislocalization of these K
+
channels. Although the conduction velocity, refractory period, and
CAP shape were not significantly altered in sciatic nerves, we
observed repetitive activities in the diaphragm following stimula-
tion of the phrenic nerve, as well as spontaneous activity. These
manifestations of hyperexcitability, corresponding to neuromyo-
tonia/myokymia, were likely due to the repetitive or spontaneous
discharge originating within peripheral axons. This hypothesis is
supported by the similarities with the phenotype observed in mice
lacking Kv1.1 channels, in which abnormalities were ascribed to
the lack of channel at the transition zone in muscular nerve
terminals [36]. Interestingly a sharp age-dependence of the
phenotype was observed in the Kv1.1 mutant mice [36], as in
4.1B mutant mice. This phenomenon may be due to myelin and/
or paranodes maturation during development insofar as a role in
the prevention of aberrant excitation as myelination proceeds has
been attributed to Kv1.1/2 channels [44]. Importantly, hyperex-
citability was increased in the presence of a K
+ channel blocker,
TEA, which blocks nodal KCNQ2/KCNQ3 channels [45,46],
suggesting that nodal K
+ channel activity may compensate for the
mislocalization of juxtaparanodal Kv1 channels. Thus, our results
indicate that 4.1B is crucial for the precise localization and
developmental function of Kv1.1/2 channels, and that 4.1B
alterations lead to a channelopathy.
Another important observation in the 4.1B mutant mice was
the existence of multiple abnormalities in the internodal region.
We confirmed that 4.1B localizes in the internodal axons and
further demonstrated that 4.1B immunoreactivity was detected
all along the internodal axolemma. In 4.1B KO mice various
alterations of the internodal axons were observed including a
slight decrease in the axonal diameter in the phrenic nerve and a
decreased variety of fiber diameters in dissociated fibers of sciatic
nerve (data not shown). These results suggest that 4.1B is
required for the precise adjustment of axon caliber. Additional
observations suggested that axonal integrity was altered: the
terminal axons caliber was irregular at the neuromuscular
junction with localized swellings. One of the best characterized
functions of proteins of the 4.1 family is to anchor b spectrins [1]
and protein 4.1B was shown to interact with bII spectrin [16].
We found that bII spectrin immunoreactivity was detected like
4.1B all along the internodal axolemma in sciatic nerve, whereas
this cortical enrichment was altered in the absence of 4.1B. bII
spectrin can associate with neurofilaments and may promote the
association of intermediate filaments with the plasma membrane
and contribute to the organization of neurofilaments [47–49].
Since neurofilaments control axonal radial growth with their
subunit composition playing a crucial role in determining normal
axonal calibers [50], 4.1B might control axonal caliber by
controlling intermediate filaments organization through its
association with bII spectrin. Interestingly, the internodal length
w h i c hi sn o r m a l l yp r o p o r t i o n a lt oa x o nc a l i b e rw a sa l s os l i g h t l y
decreased. Moreover, although no protein 4.1B labeling was
detected in Schwann cells, several abnormalities were observed
at their level including a slight increase in myelin thickness and
an increase in the number of SLIs. These modifications suggest
that the normal interactions between axons and Schwann cells
could be altered, with secondary alterations in myelinating cells.
In line of this latter possibility, the protein 4.1B/DAL-1 interacts
with the nectin-like proteins (Necl) which encompass a GNP
motif [51] and mediate heterophilic axo-glial interactions along
the internode [52,53]. These molecules may provide anchoring
sites for 4.1B along the axolemma.
In conclusion, our results show that protein 4.1B is an important
component of axons, not only at paranodes and juxtaparanodes,
but also in the internodal region. In fact the nodes are the only
axonal region completely devoid of 4.1B. The absence of protein
4.1B has different consequences depending on the regions
concerned. At paranodes 4.1B is not required for the targeting
of the axoglial complexes but for their stabilization in the axonal
membrane. By contrast, the presence of 4.1B is necessary for the
accumulation of Caspr2, TAG-1, and Kv1.1 at juxtaparanodes.
Finally, the abnormalities of internodal regions in 4.1B mutant
mice show that, presumably in interaction with bII spectrin, 4.1B
is involved in adjustment of axonal diameter. Thus, our study
demonstrates that protein 4.1B is an important player in the
axonal organization of myelinated fibers.
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Protein 4.1B mouse gene knockout mice
Mutant mice were generated by a conditional mutagenesis
strategy described in Figure S1. Briefly, three loxP sites flanking
sequentially the exon 3 of the DAL-1 gene and a PGK/Hygromycin/
GFP cassette were introduced by homologous recombination in
embryonic stem cells (ES). Recombinant mutant ES cells
(hygromycin B-resistant and GFP-positive) were injected into
C57BL/6 blastocysts and crossed with FVB/N mice to produce
outbred heterozygous offspring (protein 4.1B
flox3HygGFP/+ mice).
These were crossed with EIIACre deletor mice [54] to generate
protein 4.1B
KO3/+ mice. Protein 4.1B
KO3/+ mice were intercrossed to
obtain the mice referred as ‘‘4.1B KO mice’’ in the manuscript. All
experiments were performed in accordance with the guidelines of
the French Agriculture and Forestry Ministry for handling animals
(Decree nu 87–848). The laboratory was approved to carry out
animal experiments by the Direction De ´partementale des Services
Ve ´te ´rinaires de Paris, Service de la Protection et de la Sante ´
Animales et de la Protection de l9Environnement (licence B75-05-
22). The experimental protocols were approved by the Institut du
Fer a ` Moulin local review board. The principal investigators had a
personal agreement (JA Girault, licence 75–877; L Goutebroze,
licence 75–1533).
Antibodies
The anti-4.1B antibody was generated by immunizing rabbits
with the amino acids residues P612-L804 of rat KIAA0987 (Figure
S2) fused to GST and purified by affinity. Rabbit polyclonal
antibodies (pAb) against paranodin (L51), Caspr2, TAG-1 (TG2),
contactin/F3 and NF155, and the mouse monoclonal antibody
(mAb) against myelin protein zero (P0), have been described
previously [15,55–58]. The other antibodies were from the
following sources: voltage-gated Na
+ channel a subunit mouse
mAb (PAN Nav, clone K58/35), b-catenin rabbit pAb, neurofil-
ament 68 mouse mAb (NF-L, clone NR4), neurofilament 160
mouse mAb (NF-M, clone NN18) and neurofilament 200 rabbit
pAb (NF-H): Sigma-Aldrich (St Louis, MO); Kv1.1 a subunit
mouse mAb (clone K20/78): Antibodies Incorporated (Davis, CA);
neuronal class III b-tubulin mouse mAb (TUJ1) and phosphor-
ylated neurofilament 200 mouse mAb (SMI-31): Covance
(Berkeley, CA); bII spectrin mouse mAb (clone 42): BD
Biosciences (San Jose, CA); myelin basic protein rat mAb (MBP,
clone 12): AbD Serotec (Oxford, UK); monoclonal FITC-
conjugated sheep anti-rabbit antibodies: Eurobio (Courtaboeuf,
France); anti-mouse and anti-rabbit IRDye
TM800CW-conjugated
or IRDye
TM700CW-conjugated donkey antibodies: Rockland
Immunochemicals (Gilbertsville, PA). Cy3-conjugated goat anti-
mouse antibodies and rhodamine-conjugated a-bungarotoxin
were from Molecular Probes (Leiden, Netherlands).
Lysates preparation and immunoblotting
Tissues lysates were prepared using a lysis buffer composed of
10 mM NaPi buffer pH 7.8, 59 mM NaCl, 1% Triton-X100,
0.5% deoxycholate, 0.1% SDS, 10% glycerol, 25 mM b-
glycerophosphate, 50 mM NaF, 2 mM Na3VO4 and Complete
proteases inhibitors (Roche Diagnostics GmbH, Mannheim,
Germany). Equal amounts of protein (30 mg) were fractionated
by SDS-PAGE and transferred to nitrocellulose. Membranes were
incubated with primary antibodies followed by appropriate
IRDye-conjugated secondary antibodies, and developed and
quantified using LI-COR (Odyssey). HEK-293-4.1B lysate was
prepared from HEK293 cells stably expressing the rat 4.1B
isoform initially identified by Ohara et al. (2000) [14].
Immunofluorescence and quantitative studies
Immunostaining of teased fibers of sciatic nerves or cryostat
sections of dorsal spinal roots (10 mm) was performed as previously
described [59]. For detection of protein 4.1B, bII spectrin, and
neurofilaments in sciatic nerves, tissues were fixed in parafor-
maldhehyde 4% for 30 minutes at room temperature and teased
fibers were post-fixed with methanol/acetone 50/50 (volume/
volume) for 20 minutes at 220uC. In toto immunostaining of
neuromuscular junctions was performed as previously reported
[60]. Images were acquired at the Institut du Fer a ` Moulin Cell and
Tissue Imaging Facility, using a Leica SP2 confocal laser scanning
microscope or an epifluorescence microscope Leica DM6000
microscope equipped with a CCD camera (Leica, Mannheim,
Germany). Distances between nodes or incisures and axon
diameters were measured using MetaMorph software (Universal
Imaging Corporation, Downington, PA).
Electrophysiology
Nerve electrophysiology. Sciatic nerves were quickly
dissected, transferred into artificial cerebrospinal fluid (ACSF)
and recording of CAPs was performed at 22uC and 35uCi na
three-compartment recording chamber as previously described
[61]. Drugs were applied in the central compartment of the
chamber. For recruitment analysis, nerves were stimulated at
increasing intensities and the CAP amplitudes were plotted as a
function of the stimulation intensity. For refractory period analysis,
two successive stimuli were applied at different intervals, and the
amplitude of the second CAP was measured and plotted as a
function of the delay between the two stimuli.
Compound muscle action potential (CMAP) record-
ings. Diaphragms with the attached phrenic nerves and ribs
were quickly dissected-out, pinned down in a recording chamber
and perfused with oxygenated Rees’s solution as previously
described [62]. The phrenic nerves were stimulated with a
bipolar electrode while the nerve CAPs were recorded from the
cut end with a suction electrode. The CMAPs were recorded
simultaneously with a surface electrode pressed gently on the
diaphragm. Diaphragms were continuously superfused with
oxygenated Rees’s solution in which drugs were applied.
Recordings were made few millimeters away from the nerve
endplates, and at the same location in all experiments. Spon-
taneous and repetitive activities were analyzed using Clampfit 9.2
(Axon Instruments).
Behavioral analysis
Mice were group-housed with ad libitum access to food and water
and a 12 hours 2 12 hours light-dark cycle (light phase onset at 7
a.m.). Most experiments and initial quantitative analyses were
performed in a ‘blind’ fashion, i.e., the experimenter had no
knowledge of the genotype of the mice tested and analyzed.
Footprint pattern analysis (4- and 12-month-old
mice). The gait analysis method was adapted from de
Medinaceli et al. (1982) [63] and Ozmen et al. (2002) [64]. The
footprints were obtained by dipping mice hind paws into ink
before they walked on white paper down a confined walkway 4.5-
cm wide and 100-cm long with 10-cm high walls and a dark
shelter at the end. The footprints patterns generated were scored
for 2 parameters: step length and width (ImageJ software, NCBI).
Step length was defined as the average distance of forward
movement between at least three alternate steps. Gait width
corresponded to the average lateral distance between opposite left
and right steps. Alternation coefficient was calculated by the mean
of the absolute value of 0.5 minus the ratio of right-left distance to
right-right step distance for every left-right step pair.
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mice). Spontaneous locomotor activity was measured using a
circular corridor with four infrared beams placed at every 90u of
the inferior part of the corridor (Imetronic, Pessac, France), in a
low luminosity environment, avoiding stress. Ambulation
(crossover of two inferior adjacent beams) was quantified in 5
minutes bins during 45 minutes with a computer software
(Imetronic, Pessac, France), and cumulative counts were taken
for data analysis.
Grip strength analysis (4- to 6-month-old mice). Forelimb
grip strength was measured using a Grip Strength Meter (Bioseb,
Chaville, France) as recommended by the manufacturer. Briefly,
mice were held by the tail and allowed to grasp a grid with their
forepaws. Once the mouse grasped the grid with both paws, it was
pulled away from the grid until it released the bar. The digital meter
displayed the level of tension (in newtons) exerted on the grid by the
mouse.
Hot plate (4- to 5-month-old mice). A standard hot plate
(Bioseb, Chaville, France), adjusted to 52uC, was used to assess
motor reactions in response to noxious stimuli. The mouse was
confined on the plate by a Plexiglas cylinder (diameter 19 cm,
height 26 cm). The latency to a hind paw response (licking or
shaking) or jumping, whatever happened first, was taken as the
nociceptive threshold.
Electron microscopy and morphometry
Electron microscopy and morphometry were performed as
previously described [56]. Fibers diameters, axonal diameters, and
G-ratios, defined as ratios of axonal to fiber’s diameter were
measured automatically after segmentation, in more than 100
fibers. Five to ten nodes of Ranvier were examined in longitudinal
sections of sciatic nerves from 4- and 13-month-old mice of each
genotype (2 mice per group).
Statistical Analysis
Data in figures and text are expressed as means6s.e.m. They
were compared by Student’s t-test, Mann-Whitney non-paramet-
ric test, 1-way ANOVA followed by Bonferroni’s Multiple
Comparison Test, 2-way ANOVA followed by Bonferonni post-
tests or by 2-way RM-ANOVA test, Mantel-Cox test and Chi 2
test where appropriate, using GraphPad Prism software (Graph-
Pad Software, Inc., La Jolla, CA, USA). A P value below 0.05 was
considered to be significant.
Supporting Information
Figure S1 Generation of protein 4.1B mutant mice. A
three-lox recombination strategy [24] was used to generate mutant
mice presenting a protein 4.1B allele deleted from the exon 3 of the
Dal-1 gene (protein 4.1B
KO3). A. Generation of the protein 4.1B
KO3
allele. In a first step, A 17.0-kb protein 4.1B genomic clone
including exons 2 and 3 was isolated from a mouse 129/Ola
genomic library. A 9.5-kb NsiI-NotI fragment of this clone was used
for the construction of the protein 4.1B
lox3 targeting fragment. This
fragment was subcloned in a modified pBR322 vector containing a
NheI-SalI polylinker from pBluescript KS II (Stratagene). A 1.0-kb
ApaI-ApaI fragment containing protein 4.1B exon 3 was amplified by
PCR using primers containing loxP sites (open triangles) and was
inserted between 2 corresponding ApaI sites, flanking protein 4.1B
exon 3 of the 9.5-kb fragment. A 2.9-kb NheI-XbaI fragment
containing a floxed PGKHygromycin/GFP cassette was inserted into
a SpeI site 0.5-kb downstream of exon 3 in the same orientation of
the protein 4.1B gene. The NsiI-NotI protein 4.1B
lox3 targeting
fragment was electroporated into ES cells line E14 subclone IB10
[65]. Electroporated cells were plated on mouse embryonic
fibroblasts and selected with hygromycin B. Hygromycin-resistant
cells were trypsinized and GFP expressing cells were isolated and
then plated on 96-well microplates by flow cytometric analysis.
Homologous recombinants were identified by long-range PCR
analysis. Four of six analyzed clones showed a correct karyotype.
In the four diploid ES cell clones, 59 and 39 homologous
recombination was confirmed by Southern blot analysis using
digestions and probes. In a second step, germline chimeras (Protein
4.1B
flox3HygGFP/+) were generated by injection of protein 4.1B mutant
ES cells into C57BL/6 blastocysts and crossed with FVB/N mice
to produce outbred heterozygous offspring. The genotypes of all
offspring were analyzed by PCR or Southern blot analysis on tail-
tip DNA. To generate protein 4.1B
KO3/+ mice, protein 4.1B
flox3HygGFP/+
mice were crossed with EIIACre deletor mice [54]. In the deriving
double transgenic offspring tail DNA the protein 4.1B
KO3 allele, and
the protein 4.1B allele with two loxP sites flanking the exon 3 of the
gene (protein 4.1B
flox3 allele), were detected by PCR. Restriction
sites used for screening ((S) SwaI, (Ns) NsiI, (B) BamHI), DNA
fragments resulting from digestions (doubled-headed arrows) and
hybridization probes (A, B and Hygro (black boxes)) are indicated.
Also depicted are the PCR primers DAL1afor (59-TTCATT-
TGGTGAGATCATGG-39), DAL1arev (59-CTACCCGAAGA-
AGTGACTGG -39) and DAL1bfor (59-TAAAGTACGCTTT-
GCTCTAC-39) that detected the different alleles. B. Long range
PCR analysis to identified homologuous recombinant cells clones
using the primers DAL1a.for and DAL1a.rev (PCR product of
the protein 4.1B
flox3 allele 3.9 kb). C. Southern blot analysis of
restricted DNA from a recombinant cells clone resulting from
digestion with SwaI or BamHI. Hybridation with probes A and B
shows complete integration of the targeting fragment after homo-
logous recombination. Probe Hygro shows the single integration
of targeting fragments after homologous recombination. D, E.
Genotyping of modified protein 4.1B gene by PCR. Genomic DNA
from mice was amplified by PCR using the primers DAL1bfor and
DAL1arev to detect the protein 4.1B
flox3 allele (D) and the primers
DAL1afor and DAL1arev to detect the protein4.1B
KO3 allele (E). In
(E) protein 4.1B
KO3/+ mice were intercrossed. One litter of 11 pups
was genotyped by PCR as described above and 5 protein 4.1B
+/+
mice, 3 protein 4.1B
KO3/+ mice, and 3 protein 4.1B
KO3/KO3 mice were
found, demonstrating that protein 4.1B is not required for mouse
development. w: protein 4.1B
+/+ mice; h: protein 4.1B
KO3/+ mice; H:
protein 4.1B
KO3/KO3 mice (referred in the manuscript as ‘‘4.1B KO
mice’’).
(TIF)
Figure S2 Protein 4.1B isoforms expression in rat PNS
and CNS. A. Schematic representation of the domain structure of
rat 4.1B (KIAA0987) [4] : FERM, four point one-ezrin-radixin-
moesin domain; FA, FERM-adjacent domain; SAB, spectrin-
actin-binding domain; CTD, carboxy-terminal domain; U1, U2,
U3, domains distinct in each 4.1 protein. The amino acid residues
bordering the different domains are indicated. The position of the
protein fragment (residues P612-L804) used to raised the
antibodies (4.1B pAb) is indicated by a doubled-headed arrow.
N, amino-terminal part of the protein; C, carboxy-terminal part of
the protein. B. Immunoblots performed on lysates of rat
peripheral nerves (sciatic, brachial and trigeminal nerves) and
CNS tissues (brain, spinal cord, optic nerve). C. Immunoblots
performed on lysates of HEK293 cells expressing the rat 4.1B
isoforms initially identified by Ohara et al. (2000) [14], and lysates
of rat brain and sciatic nerve. Different isoforms of 4.1B are
preferentially expressed in the peripheral and central nervous
tissues, respectively. Main isoforms, arrows.
(TIF)
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4.1B mutant mice. Survival curves of mice over a period of 18
months. Significant increased lethality of homozygous 4.1B
mutant mice (-/-, n=27, 9 females and 18 males) after 6 months
was observed compared to heterozygous 4.1B mutant mice (+/-,
n=17, 10 females and 7 males). Dead mice were mainly diagnosed
for kidney, liver and spleen inflammation, or begnin tumors
(ovary, pituitary, mammary gland, lung) (data not shown).
Statistical test, Mantel-Cox test, Chi 2=3.974, p=0.0462.
(TIF)
Figure S4 Axonal and myelin proteins levels are not
altered in sciatic nerves from 4.1B KO mice. A, C.
Immunoblots of P0, myelin basic protein (MBP) (A), neurofilament
subunits NF-L, NF-M, NF-H, phosphorylated NF-H (NF-H-Ph),
actin (C) and neuronal class III b-tubulin (Tubulin, A, C) in sciatic
nerves from wild type (+/+), 4.1B heterozygous (+/-) and
homozygous (-/-) KO mice. B, D. Quantification of proteins
expression normalized to b-tubulin signal (three mice for each
genotype). Statistical analysis, 1-way ANOVA followed by
Bonferroni’s multiple comparison test. No significant change was
observed between the different genotypes.
(TIF)
Figure S5 CAPs from sciatic nerves of 5-month-old WT
and 4.1B KO mice recorded at 356C. A. Representative
CAPs recorded from WT and KO sciatic nerves. Superposition
(Grey) of the WT CAPs with the KO CAPs shows that conduction
is not affected in mutant animals. The places used to calculate V1/2
and Vmax are indicated (grey arrowheads). B. Normal refractory
period of the CAPs from WT and KO mice sciatic nerves. C.
Similar CAPs recruitment in sciatic nerves of WT and KO mice.
WT, n=9; KO, n=10.
(TIF)
Figure S6 Neuromuscular hyperactivity in 4.1B KO
mice during development. Evoked (A) and spontaneous (B)
neuromuscular hyperactivity was quantified during development
(2 to 25 weeks) in the absence and in the presence of the potassium
channel blocker TEA (5 mM). Note that hyperexcitability is
transient during development and that TEA exacerbates both
repetitive and spontaneous activities.
(TIF)
Acknowledgments
We thank Theano Irinopoulou (IFM cell imaging facility) for her
contribution to the acquisition of confocal microscopy images and
quantification. We also thank N. Roblot, A. Betems, R. Boukhari, and
Y. Bertelle for animal care, A. Rousseau and S. Longueville for genotyping,
V. Abramowski, H. Launay, and E. Valjent for their help with some
experiments.
Author Contributions
Conceived and designed the experiments: CCD M. Garcia JD JAG
M. Giovannini LG. Performed the experiments: CCD FC M. Garcia JD
MC M. Giovannini GL MNK LG. Analyzed the data: CCD M. Garcia JD
GL JAG M. Giovannini LG. Contributed reagents/materials/analysis
tools: SH. Wrote the paper: CCD JD JAG LG.
References
1. Diakowski W, Grzybek M, Sikorski AF (2006) Protein 4.1, a component of the
erythrocyte membrane skeleton and its related homologue proteins forming the
protein 4.1/FERM superfamily. Folia Histochem Cytobiol 44: 231–248.
2. Ni X, Ji C, Cao G, Cheng H, Guo L, et al. (2003) Molecular cloning and
characterization of the protein 4.1O gene, a novel member of the protein 4.1
family with focal expression in ovary. J Hum Genet 48: 101–106.
3. Yamakawa H, Ohara R, Nakajima D, Nakayama M, Ohara O (1999)
Molecular characterization of a new member of the protein 4.1 family (brain
4.1) in rat brain. Brain Res Mol Brain Res 70: 197–209.
4. Parra M, Gascard P, Walensky LD, Gimm JA, Blackshaw S, et al. (2000)
Molecular and functional characterization of protein 4.1B, a novel member of
the protein 4.1 family with high level, focal expression in brain. J Biol Chem 275:
3247–3255.
5. Tran YK, Bogler O, Gorse KM, Wieland I, Green MR, et al. (1999) A novel
member of the NF2/ERM/4.1 superfamily with growth suppressing properties
in lung cancer. Cancer Res 59: 35–43.
6. Gutmann DH, Donahoe J, Perry A, Lemke N, Gorse K, et al. (2000) Loss of
DAL-1, a protein 4.1-related tumor suppressor, is an important early event in
the pathogenesis of meningiomas. Hum Mol Genet 9: 1495–1500.
7. Singh PK, Gutmann DH, Fuller CE, Newsham IF, Perry A (2002) Differential
involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and
intraspinal ependymomas. Mod Pathol 15: 526–531.
8. Charboneau AL, Singh V, Yu T, Newsham IF (2002) Suppression of growth and
increased cellular attachment after expression of DAL-1 in MCF-7 breast cancer
cells. Int J Cancer 100: 181–188.
9. Ohno N, Terada N, Murata S, Yamakawa H, Newsham IF, et al. (2004)
Immunolocalization of protein 4.1B/DAL-1 during neoplastic transformation of
mouse and human intestinal epithelium. Histochem Cell Biol 122: 579–586.
10. Wong SY, Haack H, Kissil JL, Barry M, Bronson RT, et al. (2007) Protein 4.1B
suppresses prostate cancer progression and metastasis. Proc Natl Acad Sci U S A
104: 12784–12789.
11. Heller G, Geradts J, Ziegler B, Newsham I, Filipits M, et al. (2007)
Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast
cancer. Breast Cancer Res Treat 103: 283–291.
12. Salzer JL, Brophy PJ, Peles E (2008) Molecular domains of myelinated axons in
the peripheral nervous system. Glia 56: 1532–1540.
13. Susuki K, Rasband MN (2008) Molecular mechanisms of node of Ranvier
formation. Curr Opin Cell Biol 20: 616–623.
14. Ohara R, Yamakawa H, Nakayama M, Ohara O (2000) Type II brain 4.1
(4.1B/KIAA0987), a member of the protein 4.1 family, is localized to neuronal
paranodes. Brain Res Mol Brain Res 85: 41–52.
15. Denisenko-Nehrbass N, Oguievetskaia K, Goutebroze L, Galvez T,
Yamakawa H, et al. (2003) Protein 4.1B associates with both Caspr/paranodin
and Caspr2 at paranodes and juxtaparanodes of myelinated fibres.
Eur J Neurosci 17: 411–416.
16. Ogawa Y, Schafer DP, Horresh I, Bar V, Hales K, et al. (2006) Spectrins and
ankyrinB constitute a specialized paranodal cytoskeleton. J Neurosci 26:
5230–5239.
17. Horresh I, Bar V, Kissil JL, Peles E (2010) Organization of myelinated axons by
Caspr and Caspr2 requires the cytoskeletal adapter protein 4.1B. J Neurosci 30:
2480–2489.
18. Buttermore ED, Dupree JL, Cheng J, An X, Tessarollo L, et al. (2011) The
cytoskeletal adaptor protein band 4.1B is required for the maintenance of
paranodal axoglial septate junctions in myelinated axons. J Neurosci 31:
8013–8024.
19. Poliak S, Gollan L, Salomon D, Berglund EO, Ohara R, et al. (2001)
Localization of Caspr2 in myelinated nerves depends on axon-glia interactions
and the generation of barriers along the axon. J Neurosci 21: 7568–7575.
20. Girault JA, Labesse G, Mornon JP, Callebaut I (1998) Janus kinases and focal
adhesion kinases play in the 4.1 band: a superfamily of band 4.1 domains
important for cell structure and signal transduction. Mol Med 4: 751–769.
21. Gollan L, Sabanay H, Poliak S, Berglund EO, Ranscht B, et al. (2002) Retention
of a cell adhesion complex at the paranodal junction requires the cytoplasmic
region of Caspr. J Cell Biol 157: 1247–1256.
22. Traka M, Goutebroze L, Denisenko N, Bessa M, Nifli A, et al. (2003)
Association of TAG-1 with Caspr2 is essential for the molecular organization of
juxtaparanodal regions of myelinated fibers. J Cell Biol 162: 1161–1172.
23. Sun XY, Takagishi Y, Okabe E, Chishima Y, Kanou Y, et al. (2009) A novel
Caspr mutation causes the shambling mouse phenotype by disrupting axoglial
interactions of myelinated nerves. J Neuropathol Exp Neurol 68: 1207–1218.
24. Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stoffel M, et al. (2002)
beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and
glucose intolerance but does not alter beta-cell mass. Nat Genet 31: 111–115.
25. Gascard P, Parra MK, Zhao Z, Calinisan VR, Nunomura W, et al. (2004)
Putative tumor suppressor protein 4.1B is differentially expressed in kidney and
brain via alternative promoters and 59 alternative splicing. Biochim Biophys
Acta 1680: 71–82.
26. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, et al. (1996) Exon 1
of the HD gene with an expanded CAG repeat is sufficient to cause a progressive
neurological phenotype in transgenic mice. Cell 87: 493–506.
27. Yang Y, Lacas-Gervais S, Morest DK, Solimena M, Rasband MN (2004)
BetaIV spectrins are essential for membrane stability and the molecular
organization of nodes of Ranvier. J Neurosci 24: 7230–7240.
28. Peles E, Nativ M, Lustig M, Grumet M, Schilling J, et al. (1997) Identification of
a novel contactin-associated transmembrane receptor with multiple domains
implicated in protein-protein interactions. EMBO J 16: 978–988.
Role of Protein 4.1B in Myelinated Axons
PLoS ONE | www.plosone.org 14 September 2011 | Volume 6 | Issue 9 | e2504329. Charles P, Tait S, Faivre-Sarrailh C, Barbin G, Gunn-Moore F, et al. (2002)
Neurofascin is a glial receptor for the paranodin/Caspr-contactin axonal
complex at the axoglial junction. Curr Biol 12: 217–220.
30. Gollan L, Salomon D, Salzer JL, Peles E (2003) Caspr regulates the processing of
contactin and inhibits its binding to neurofascin. J Cell Biol 163: 1213–1218.
31. Bonnon C, Bel C, Goutebroze L, Maigret B, Girault JA, et al. (2007) PGY
repeats and N-glycans govern the trafficking of paranodin and its selective
association with contactin and neurofascin-155. Mol Biol Cell 18: 229–241.
32. Poliak S, Salomon D, Elhanany H, Sabanay H, Kiernan B, et al. (2003)
Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons
depends on Caspr2 and TAG-1. J Cell Biol 162: 1149–1160.
33. Friede RL (1983) Variance in relative internode length (l/d) in the rat and its
presumed significance for the safety factor and neuropathy. J Neurol Sci 60:
89–104.
34. Fannon AM, Sherman DL, Ilyina-Gragerova G, Brophy PJ, Friedrich VL Jr.,
et al. (1995) Novel E-cadherin-mediated adhesion in peripheral nerve: Schwann
cell architecture is stabilized by autotypic adherens junctions. J Cell Biol 129:
189–202.
35. Chang BJ, Cho IJ, Brophy PJ (2000) A study on the immunocytochemical
localization of neurofascin in rat sciatic nerve. J Vet Sci 1: 67–71.
36. Zhou L, Zhang CL, Messing A, Chiu SY (1998) Temperature-sensitive
neuromuscular transmission in Kv1.1 null mice: role of potassium channels
under the myelin sheath in young nerves. J Neurosci 18: 7200–7215.
37. Zhou Z, Vorperian VR, Gong Q, Zhang S, January CT (1999) Block of HERG
potassium channels by the antihistamine astemizole and its metabolites
desmethylastemizole and norastemizole. J Cardiovasc Electrophysiol 10:
836–843.
38. Bhat MA, Rios JC, Lu Y, Garcia-Fresco GP, Ching W, et al. (2001) Axon-glia
interactions and the domain organization of myelinated axons requires neurexin
IV/Caspr/Paranodin. Neuron 30: 369–383.
39. Boyle ME, Berglund EO, Murai KK, Weber L, Peles E, et al. (2001) Contactin
orchestrates assembly of the septate-like junctions at the paranode in myelinated
peripheral nerve. Neuron 30: 385–397.
40. Yi C, McCarty JH, Troutman SA, Eckman MS, Bronson RT, et al. (2005) Loss
of the putative tumor suppressor band 4.1B/Dal1 gene is dispensable for normal
development and does not predispose to cancer. Mol Cell Biol 25: 10052–10059.
41. Wang H, Kunkel DD, Martin TM, Schwartzkroin PA, Tempel BL (1993)
Heteromultimeric K+ channels in terminal and juxtaparanodal regions of
neurons. Nature 365: 75–79.
42. Horresh I, Poliak S, Grant S, Bredt D, Rasband MN, et al. (2008) Multiple
molecular interactions determine the clustering of Caspr2 and Kv1 channels in
myelinated axons. J Neurosci 28: 14213–14222.
43. Ogawa Y, Oses-Prieto J, Kim MY, Horresh I, Peles E, et al. (2010) ADAM22, a
Kv1 channel-interacting protein, recruits membrane-associated guanylate
kinases to juxtaparanodes of myelinated axons. J Neurosci 30: 1038–1048.
44. Vabnick I, Trimmer JS, Schwarz TL, Levinson SR, Risal D, et al. (1999)
Dynamic potassium channel distributions during axonal development prevent
aberrant firing patterns. J Neurosci 19: 747–758.
45. Devaux J, Gola M, Jacquet G, Crest M (2002) Effects of K+ channel blockers on
developing rat myelinated CNS axons: identification of four types of K+
channels. J Neurophysiol 87: 1376–1385.
46. Devaux JJ, Kleopa KA, Cooper EC, Scherer SS (2004) KCNQ2 is a nodal K+
channel. J Neurosci 24: 1236–1244.
47. Langley RC Jr., Cohen CM (1987) Cell type-specific association between two
types of spectrin and two types of intermediate filaments. Cell Motil
Cytoskeleton 8: 165–173.
48. Frappier T, Stetzkowski-Marden F, Pradel LA (1991) Interaction domains of
neurofilament light chain and brain spectrin. Biochem J 275: 521–527.
49. Macioce P, Gandolfi N, Leung CL, Chin SS, Malchiodi-Albedi F, et al. (1999)
Characterization of NF-L and betaIISigma1-spectrin interaction in live cells.
Exp Cell Res 250: 142–154.
50. Julien JP (1999) Neurofilament functions in health and disease. Curr Opin
Neurobiol 9: 554–560.
51. Yageta M, Kuramochi M, Masuda M, Fukami T, Fukuhara H, et al. (2002)
Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins
in lung cancer. Cancer Res 62: 5129–5133.
52. Maurel P, Einheber S, Galinska J, Thaker P, Lam I, et al. (2007) Nectin-like
proteins mediate axon Schwann cell interactions along the internode and are
essential for myelination. J Cell Biol 178: 861–874.
53. Spiegel I, Adamsky K, Eshed Y, Milo R, Sabanay H, et al. (2007) A central role
for Necl4 (SynCAM4) in Schwann cell-axon interaction and myelination. Nat
Neurosci 10: 861–869.
54. Leneuve P, Colnot S, Hamard G, Francis F, Niwa-Kawakita M, et al. (2003)
Cre-mediated germline mosaicism: a new transgenic mouse for the selective
removal of residual markers from tri-lox conditional alleles. Nucleic Acids Res
31: e21.
55. Menegoz M, Gaspar P, Le Bert M, Galvez T, Burgaya F, et al. (1997)
Paranodin, a glycoprotein of neuronal paranodal membranes. Neuron 19:
319–331.
56. Denisenko N, Cifuentes-Diaz C, Irinopoulou T, Carnaud M, Benoit E, et al.
(2008) Tumor suppressor schwannomin/merlin is critical for the organization of
Schwann cell contacts in peripheral nerves. J Neurosci 28: 10472–10481.
57. Zonta B, Tait S, Melrose S, Anderson H, Harroch S, et al. (2008) Glial and
neuronal isoforms of Neurofascin have distinct roles in the assembly of nodes of
Ranvier in the central nervous system. J Cell Biol 181: 1169–1177.
58. Yoshimura K, Negishi T, Kaneko A, Sakamoto Y, Kitamura K, et al. (1996)
Monoclonal antibodies specific to the integral membrane protein P0 of bovine
peripheral nerve myelin. Neurosci Res 25: 41–49.
59. Goutebroze L, Carnaud M, Denisenko N, Boutterin MC, Girault JA (2003)
Syndecan-3 and syndecan-4 are enriched in Schwann cell perinodal processes.
BMC Neurosci 4: 29.
60. Cifuentes-Diaz C, Nicole S, Velasco ME, Borra-Cebrian C, Panozzo C, et al.
(2002) Neurofilament accumulation at the motor endplate and lack of axonal
sprouting in a spinal muscular atrophy mouse model. Hum Mol Genet 11:
1439–1447.
61. Lonigro A, Devaux JJ (2009) Disruption of neurofascin and gliomedin at nodes
of Ranvier precedes demyelination in experimental allergic neuritis. Brain 132:
260–273.
62. Devaux JJ (2010) The C-terminal domain of ssIV-spectrin is crucial for KCNQ2
aggregation and excitability at nodes of Ranvier. J Physiol 588: 4719–4730.
63. de Medinaceli L, Freed WJ, Wyatt RJ (1982) An index of the functional
condition of rat sciatic nerve based on measurements made from walking tracks.
Exp Neurol 77: 634–643.
64. Ozmen S, Ayhan S, Latifoglu O, Siemionow M (2002) Stamp and paper
method: a superior technique for the walking track analysis. Plast Reconstr Surg
109: 1760–1761.
65. Robanus-Maandag E, Dekker M, van der Valk M, Carrozza ML, Jeanny JC,
et al. (1998) p107 is a suppressor of retinoblastoma development in pRb-deficient
mice. Genes Dev 12: 1599–1609.
Role of Protein 4.1B in Myelinated Axons
PLoS ONE | www.plosone.org 15 September 2011 | Volume 6 | Issue 9 | e25043